Cholesteryl n-alkanoates of saturated fatty acids
and their mixtures are widely studied in different physical states
and also due to their significance in biology. Here, we address the
miscibility of some homologues of cholesteryl n-alkanoates
at interfaces, which are known to exhibit different (cholesteryl octanoate,
ChC8, and cholesteryl stearate, ChC18) or the same (cholesteryl nonanoate,
ChC9, and cholesteryl laurate, ChC12) molecular packing in bulk. Surface
manometry and Brewster angle microscopy studies on ChC8 (cholesteryl–cholesteryl
interaction, referred to as m-i packing)/ChC9 (cholesteryl–chain
interaction, referred to as m-ii packing) and also
on ChC18 (chain–chain interactions, referred to as the crystalline
bilayer)/ChC9 mixtures reveal phase separation at the air–water
(A–W) interface plausibly due to the difference in the molecular
packing. In contrast, ChC12/ChC9 (both m-ii packing)
mixtures form a homogeneous phase and exhibit a higher collapse pressure
(almost twice) than that of ChC9 indicating higher stability. At the
air–solid (A–S) interface, the height profiles extracted
from the surface topography images using an atomic force microscope
yielded thicknesses of 3.6 ± 0.1 and 5.6 ± 0.1 nm for ChC18/ChC9
mixtures (at 0.66 and 0.5 mole fractions (MF)) corresponding to individual
assembly, whereas a uniform thickness of 3.5 ± 0.2 nm is obtained
for the case of ChC12/ChC9 mixtures (at 0.2, 0.5, and 0.8 MF) corresponding
to m-ii packing. Ellipsometry studies reveal that
the desorption temperature increases with the mole fraction of ChC9
and attains a maximum at 406.8 ± 4.8 K for 0.4 MF of ChC9, beyond
which it decreases. Raman spectroscopy studies are carried out for
ChC12/ChC9 mixtures in the homogeneous phase and in the collapsed
state. Here, the dependency of peak positions on different physical
states was assessed. Our studies offer new insights into the compatibility
of molecular packing influencing the phase behavior and may be of
relevance to tear film studies and on the formation of crystals in
atherosclerosis.